eCORP Stimulation Technologies, LLC (ecorpStim) announced yesterday the addition of the Glass Technology Services (GTS), Sheffield, UK, to ecorpStim’s clean shale stimulation research and development consortium.
ecorpStim was created in 2012 to provide European countries, as well as those with limited water resources, with alternatives to hydraulic fracturing, based on pure home grade propane and without the use of chemicals, or on heptafluoropropane (in the case of NFP Stimulation).
GTS on the other hand, is a multi-disciplinary centre for testing, consultancy and research and development – specialising in glass and related materials. Accredited to ISO 9001, 14001 and 17025 standards, GTS provides a wide range of services to food and drink manufacturers, the design and construction industry, medical, pharmaceutical and biotech sectors, energy and defense sectors across the UK and internationally.
Scientists at GTS will assist ecorpStim research team – which includes doctors and scientists at Baylor College of Medicine, Rice University, the Energy Safety Research Institute at Swansea University, and its collaborative partner University of Grenoble – in evaluating and furthering developments in delivery of ecorpStim’s non-water, chemical-free stimulation technologies.
The addition of GTS to the ecorpStim research consortium is important to furthering the company’s goals of advancing proprietary concepts for the use of silica, the raw material with which glass is made, in the environmentally sustainable development of shale hydrocarbon production.
One such patent pending technology involves the novel combination of two components only – a stimulation fluid (heptafluoropropane) and a proppant (mesoporous silica) – both of which are approved in different forms of medical treatments.
ecorpStim’s proprietary (patent pending) Pure Propane Stimulation and Non-Flammable Propane Stimulation technologies are being developed to reduce the environmental impacts associated with shale development to being only clean and temporary use of the well site. ecorpStim’s shale stimulation designs and operating practices constitute a revolutionary change for the industry.
John Francis Thrash, M.D., CEO of ecorpStim, observed that “The unique use of these two agents that are approved for medical use helps to further advance our goals of providing stimulation technologies for the extraction of shale gas that are at the same time completely innocuous for human health and fully respectful of the environment. Ecological shale development can be expected to fuel massive job creation as much as it can fuel the economy of the producing and exporting country.”
Article continues below this message
Have your opinion heard with Shale Gas International
We accept interesting, well-written opinion and analysis articles of up to 1,500 words, that offer unique insights into the shale industry. The articles cannot be overtly promotional in nature and need to fit into at least one of our content categories.
If accepted, the article must be exclusive to Shale Gas International website and cannot appear on any other websites, publications, etc. Each article may contain up to three links to external websites relevant to the content discussed in the piece.
If you would like to contribute to Shale Gas International website, please contact us at: editor[at]mw-ep.com